155 results
Page 4 of 8
8-K
pqsdy3wn7t zml
13 Oct 20
Other Events
5:04pm
8-K
EX-99.1
ofku50o
7 Oct 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
igo8fcv ieji99y9r
7 Aug 20
Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Update
7:23am
8-K
EX-99.1
xdil3rm7dsrt2 vl6
17 Jul 20
DEXTENZA® Sets Billable Insert In-Market Sales Record in June and Company Announces Preliminary Second Quarter 2020 Net Product Revenue
7:34am
8-K
EX-99.1
er2z2yi3engnrc
16 Jul 20
Results of Operations and Financial Condition
9:17am
8-K
877 o832vrdtkxtw5t
6 Jul 20
Other Events
8:15am
8-K
EX-99.1
y5xlx6g
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
8-K
EX-1.1
20i1h78a2ojqxhn519
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
8-K
EX-99.2
13v0ujw
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
424B5
jr9d5h naj
20 May 20
Prospectus supplement for primary offering
4:27pm
424B5
lxy5may413f1cdbguf2
19 May 20
Prospectus supplement for primary offering
4:54pm
8-K
eyjiz8u3vibhjvhp1wbp
14 May 20
Entry into a Material Definitive Agreement
4:36pm
8-K
EX-99.1
omer ka985c5g
8 May 20
Ocular Therapeutix™ Reports First Quarter 2020 Financial Results and Business Update
7:05am
8-K
EX-99.1
oj8n n05u
13 Apr 20
Ocular Therapeutix™ Provides Business Update and Response to COVID-19 Global Pandemic
8:05am